Exercise apparatus with elliptical foot motion

Details for Australian Patent Application No. 2004260676 (hide)

Owner Stearns Technologies, Inc.

Inventors Maresh, Joseph D.; Stearns, Kenneth W.

Agent A J Park

Pub. Number AU-A-2004260676

PCT Pub. Number WO2005/011815

Priority 10/633,042 01.08.03 US

Filing date 30 July 2004

Wipo publication date 10 February 2005

International Classifications

A63B 22/00 (2006.01) Exercising apparatus specially adapted for conditioning the cardio-vascular system, for training agility or co-ordination of movements

A63B 22/04 (2006.01) Exercising apparatus specially adapted for conditioning the cardio-vascular system, for training agility or co-ordination of movements

A63B 22/06 (2006.01) Exercising apparatus specially adapted for conditioning the cardio-vascular system, for training agility or co-ordination of movements - with rotating cycling movement

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/011815 Priority application(s): WO2005/011815

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260678-Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease

2004260665-Hepatitis virus core proteins as vaccine platforms and methods of use thereof